Search - tctmd.com

Displaying 61 - 80 of 98

Sort: Relevancy | Date

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

Shelley Wood

September 29, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

Presentation TCT 2019

Why RCTs Comparing EVAR With Open Repair for Ruptured AAAs are Misleading and Not Generally Applicable: EVAR is Best if it Can be Done

Presenter: Frank Veith

September 27, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

Safety of PTX Devices for PAD in Japan: Academic View

Presenter: Masato Nakamura

September 26, 2019

Presentation TCT 2019

Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data

Presenter: Roseann White

September 26, 2019

Presentation TCT 2019

Moving From “Signal Detection” to “Signal Discernment”: An FDA View

Presenter: Eleni Whatley

September 26, 2019

Presentation TCT 2018

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

Presenter: Teiji Akagi, John D. Carroll, Konstantinos Dean Boudoulas

September 22, 2018

Presentation TCT 2018

EffPac-RCT: A Randomized Trial Evaluating a Drug-Coated Balloon in Superficial Femoral and Popliteal Arteries

Presenter: Lindsay S. Machan, Craig M. Walker, Marcus Thieme

September 22, 2018

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

Presentation TCT 2017

New Insights From AIDA: Subgroups and Predictors of Adverse Events

Presenter: Azeem Latib, Joanna J. Wykrzykowska

October 31, 2017

Presentation TCT 2017

Neochord for Degenerative MR: Data Synthesis and RCT Progress

Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Khalil Fattouch

October 30, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

Presentation TCT 2017

Carillon Indirect Annuloplasty for Functional MR: Data Synthesis and RCT Progress

Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Wilson Y. Szeto

October 30, 2017

Advertisement

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

TCT 2019 Day Four: Costs and Quality of Life Take Center Stage

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Portico Noninferior to Commercial TAVR Valves in IDE Study

Why RCTs Comparing EVAR With Open Repair for Ruptured AAAs are Misleading and Not Generally Applicable: EVAR is Best if it Can be Done

Remaining Data Gaps After the Low-Risk TAVR RCTs

Safety of PTX Devices for PAD in Japan: Academic View

Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data

Moving From “Signal Detection” to “Signal Discernment”: An FDA View

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

EffPac-RCT: A Randomized Trial Evaluating a Drug-Coated Balloon in Superficial Femoral and Popliteal Arteries

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

New Insights From AIDA: Subgroups and Predictors of Adverse Events

Neochord for Degenerative MR: Data Synthesis and RCT Progress

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Carillon Indirect Annuloplasty for Functional MR: Data Synthesis and RCT Progress

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content